• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Creating more potent cancer therapy using ‘theranostics’

Bioengineer by Bioengineer
March 5, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The therapy plus diagnostics — theranostics — a City of Hope scientist and his peers developed has the potential to better target disease and reduce side effects

DUARTE, Calif. — A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” – therapy combined with diagnostics – that target specific tumors and diseases.

Key to the process are molecules called metallocorroles, which serve as versatile platforms for the development of drugs and imaging agents. City of Hope’s John Termini, Ph.D., and his colleagues at the California Institute of Technology and the Israel Institute of Technology developed a novel method to prepare cell-penetrating nanoparticles called “metallocorrole/protein nanoparticles.” The theranostics could both survive longer in the body and better snipe disease targets.

“This study is just one of City of Hope’s many ongoing research projects that aim to move the field from conventional medicine to precision medicine, where therapies are tailored for specific individuals,” said Termini, a molecular medicine professor at City of Hope.

The study, published in Scientific Reports, a Nature publication, on Feb. 19, details a unique way the researchers prepared the theranostics that may be generalizable to many similar molecules.

“Through collaborative brainpower, we were able to create something that has huge chemotherapeutic potential,” Termini said. “Down the road, theranostics such as this could shorten treatment duration and diminish the dreaded side effects so many cancer patients fear.”

###

The study was supported by an international collaboration grant from the Jacki and Bruce Barron Cancer Research Scholars’ Program, The Harvey L. Miller Family Foundation, the National Institutes of Health and the Caltech/City of Hope Biomedical Initiative.

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked one of America’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

Media Contact
Zen Vuong
[email protected]

Tags: BiologyCell BiologyDiagnosticsMolecular Biology
Share14Tweet8Share2ShareShareShare2

Related Posts

Next-Gen Engineered T Cell Innovations Unveiled

October 11, 2025

Black Women Mental Health Workers: Dual Perspectives Explored

October 11, 2025

Paternal COVID-19 Alters Sperm RNA, Raises Offspring Anxiety

October 11, 2025

Revolutionizing Immunotherapy: Mass Production of CAR-iNK Cells

October 11, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1208 shares
    Share 482 Tweet 302
  • New Study Reveals the Science Behind Exercise and Weight Loss

    102 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    97 shares
    Share 39 Tweet 24
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    87 shares
    Share 35 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pristine Interface of Zirconium Oxide and MoS₂

Perovskites Revolutionize Next-Gen Color Conversion Displays

Next-Gen Engineered T Cell Innovations Unveiled

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.